{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:46:57Z","timestamp":1774615617076,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008854","name":"University of Zanjan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.imbio.2020.151984","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T01:45:27Z","timestamp":1593999927000},"page":"151984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["In vitro immunobiological assays of methotrexate-stearic acid conjugate in human PBMCs"],"prefix":"10.1016","volume":"225","author":[{"given":"Nadia","family":"Fattahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Bahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ramazani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davoud","family":"Koolivand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2020.151984_bib0005","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ejmech.2018.07.045","article-title":"Methotrexate prodrugs sensitive to reactive oxygen species for the improved treatment of rheumatoid arthritis","volume":"156","author":"Andersen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.imbio.2020.151984_bib0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.toxlet.2017.05.005","article-title":"Environmentally relevant dose of arsenic interferes in functions of human monocytes derived dendritic cells","volume":"275","author":"Bahari","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.imbio.2020.151984_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08923973.2013.850506","article-title":"Cytochrome P450 isoforms are differently up-regulated in aflatoxin B1-exposed human lymphocytes and monocytes","volume":"36","author":"Bahari","year":"2014","journal-title":"Immunopharm. Immunotoxicol."},{"key":"10.1016\/j.imbio.2020.151984_bib0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/1547691X.2014.925994","article-title":"GST-M1 is transcribed moreso than AKR7A2 in AFB1-exposed human monocytes and lymphocytes","volume":"12","author":"Bahari","year":"2015","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.imbio.2020.151984_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.1993.11.1.5","article-title":"Karnofsky memorial lecture. Ode to methotrexate","volume":"11","author":"Bertino","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.imbio.2020.151984_bib0030","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/mp060132k","article-title":"Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model","volume":"4","author":"Chen","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.imbio.2020.151984_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.imbio.2020.151984_bib0040","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/mnfr.201100685","article-title":"Gene expression of peripheral blood mononuclear cells as a tool in dietary intervention studies: what do we know so far?","volume":"56","author":"de Mello","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.imbio.2020.151984_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/859383","article-title":"Mechanisms of thymoquinone hepatorenal protection in methotrexate-induced toxicity in rats","volume":"2015","author":"El-Sheikh","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.imbio.2020.151984_bib0050","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.addr.2012.07.012","article-title":"Fatty acids as therapeutic auxiliaries for oral and parenteral formulations","volume":"65","author":"Hackett","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.imbio.2020.151984_bib0055","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/acs.molpharmaceut.6b01027","article-title":"Lipid\u2013drug conjugate for enhancing drug delivery","volume":"14","author":"Irby","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.imbio.2020.151984_bib0060","first-page":"349","volume":"vol. 10","author":"Janeway","year":"1998"},{"key":"10.1016\/j.imbio.2020.151984_bib0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.chemphyslip.2008.11.005","article-title":"Liposomes containing alkylated methotrexate analogues for phospholipase A 2 mediated tumor targeted drug delivery","volume":"157","author":"Kaasgaard","year":"2009","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.imbio.2020.151984_bib0070","series-title":"Major Side Effects of Low Dose Methotrexate","author":"Kremer","year":"2011"},{"key":"10.1016\/j.imbio.2020.151984_bib0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4161\/rna.27863","article-title":"Sustained stabilization of Interleukin-8 mRNA in human macrophages","volume":"11","author":"Mahmoud","year":"2014","journal-title":"RNA Biol."},{"key":"10.1016\/j.imbio.2020.151984_bib0080","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2174\/1389450117666151209115431","article-title":"Design of lipophilic prodrugs to improve drug delivery and efficacy","volume":"17","author":"Mandal","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.imbio.2020.151984_bib0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2020.151984_bib0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2018.03.008","article-title":"Immunobiologically relevant level of aflatoxin B 1 alters transcription of key functional immune genes, phagocytosis and survival of human dendritic cells","volume":"197","author":"Mehrzad","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imbio.2020.151984_bib0095","first-page":"2285","article-title":"Novel formulation of a methotrexate derivative with a lipid nanoemulsion","volume":"6","author":"Moura","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.imbio.2020.151984_bib0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/annrheumdis-2017-212537","article-title":"Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism","volume":"77","author":"Municio","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imbio.2020.151984_bib0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.imbio.2020.151984_bib0110","first-page":"189","article-title":"Abrogation of 5-flourouracil induced renal toxicity by bee propolis via targeting oxidative stress and inflammation in Wistar rats","volume":"7","author":"Rashid","year":"2013","journal-title":"J. Pharm. Pract. Res."},{"key":"10.1016\/j.imbio.2020.151984_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.imbio.2020.151984_bib0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrd.2018.46","article-title":"The expanding role of prodrugs in contemporary drug design and development","volume":"17","author":"Rautio","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.imbio.2020.151984_bib0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/annrheumdis-2014-206305","article-title":"Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation","volume":"75","author":"Thornton","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imbio.2020.151984_bib0130","first-page":"345","article-title":"Effectiveness of subcutaneous methotrexate in chronic plaque psoriasis","volume":"15","author":"Yesudian","year":"2016","journal-title":"J. Drugs Dermatol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520302345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520302345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:46:11Z","timestamp":1759250771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298520302345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0171298520302345"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2020.151984","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro immunobiological assays of methotrexate-stearic acid conjugate in human PBMCs","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2020.151984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151984"}}